Deaths: Younger Age Cohorts

Lord Strathcarron Excerpts

Thursday 11th January 2024 Lords Chamber

Asked by

[Lord Strathcarron]

To ask His Majesty’s Government what assessment they have made of the level of (1) excess deaths not attributable to COVID-19, particularly coronary and vascular-related excess deaths, and (2) excess deaths in younger age cohorts, since 1 January 2020.

[Lord Evans of Rainow (Con)]

My Lords, the Office for Health Improvement and Disparities has estimated excess deaths for non-specific Covid disease groups. Across the course of the pandemic to date, deaths involving cardiovascular diseases were 12% higher than expected. Deaths from all causes in people under 65 were 13% higher than expected. We are acting to reduce excess deaths, including those involving Covid-19, by rolling out vaccination programmes, tackling elective backlogs and through action on preventable conditions such as cardiovascular diseases.

[Lord Strathcarron (Con)]

I thank my noble friend the Minister for his reply. Converting these statistics to reality means that 60,000 people died last year, mostly from heart-related conditions, at a much younger age than they would have been expected to before the pandemic and, in particular, our response to it. Could my noble friend suggest to the official Covid inquiry that, rather than concentrating on the tittle-tattle of WhatsApp messages, it considers whether lockdowns did more overall health harm than good—as evidence from around the world now suggests they did? Could it also investigate why, according to submissions already made to it, the UK has considerably higher excess mortality than other similar countries and in what way lockdowns and other interventions are linked to last year’s 60,000 young deaths, with no doubt more to come this year?

[Lord Evans of Rainow (Con)]

My Lords, I am most grateful for the noble Lord’s excellent question. The Office for Health Improvement and Disparities estimates that, from the start of the pandemic to date, the total number of excess deaths in younger cohorts—that is, those under 65—is just under 38,000. Across all ages, this is likely due to a combination of factors, including flu prevalence, the impact of Covid-19 and the continued prevalence of conditions such as cardiovascular diseases. Vaccines are our first line of defence and millions have received their jab in our autumn campaign. As regards the Covid-19 inquiry, it is an independent public inquiry and will determine the issues it chooses to explore within the parameters of its terms of reference.